Corbus Pharma (CRBP) Granted Patent Covering Use of Anabasum for Treatment of Rare Fibrotic Diseases
Tweet Send to a Friend
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) announced today that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Patent No ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
